Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)
Centro de investigación
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Valencia, EspañaPublicacións en colaboración con investigadores/as de Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (29)
2023
-
Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort study
Vaccine, Vol. 41, Núm. 1, pp. 251-262
2022
-
Severe Acute Respiratory Syndrome Coronavirus 2 Adaptive Immunity in Nursing Home Residents Following a Third Dose of the Comirnaty Coronavirus Disease 2019 Vaccine
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 75, Núm. 1, pp. e865-e868
2021
-
Spread of a SARS-CoV-2 variant through Europe in the summer of 2020
Nature, Vol. 595, Núm. 7869, pp. 707-712
2019
-
Feasibility of point-of-care testing for influenza within a national primary care sentinel surveillance network in England: Protocol for a mixed methods study
JMIR Research Protocols, Vol. 8, Núm. 11
-
Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials
Human Vaccines and Immunotherapeutics, Vol. 15, Núm. 12, pp. 2865-2872
2018
2017
-
Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza
Vaccine, Vol. 35, Núm. 34, pp. 4298-4306
2014
-
It is time to abandon "expected bladder capacity." Systematic review and new models for children's normal maximum voided volumes
Neurourology and Urodynamics, Vol. 33, Núm. 7, pp. 1092-1098
-
Optimizing strategies for meningococcal C disease vaccination in Valencia (Spain)
BMC Infectious Diseases, Vol. 14, Núm. 1
-
Safety and immunogenicity of a vero cell culture-derived whole-virus influenza a(H5N1) vaccine in a pediatric population
Journal of Infectious Diseases, Vol. 209, Núm. 1, pp. 12-23
2013
-
Evaluation of 13-valent pneumococcal conjugate vaccine and concomitant meningococcal group C conjugate vaccine in healthy infants and toddlers in Spain
Vaccine, Vol. 31, Núm. 46, pp. 5486-5494
-
Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule
Vaccine, Vol. 31, Núm. 42, pp. 4765-4774
-
MF59-adjuvanted and virosomal influenza vaccines for preventing influenza hospitalization in older people: Comparative effectiveness using the Valencia health care information system
Vaccine, Vol. 31, Núm. 37, pp. 3995-4002
-
Mortality due to haematological cancer in cities close to petroleum refineries in Spain
Environmental Science and Pollution Research, Vol. 20, Núm. 1, pp. 591-596
2012
-
Effectiveness of the 2010-2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: A case-case comparison, case-control study
Vaccine, Vol. 30, Núm. 39, pp. 5714-5720
-
Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: A randomized controlled trial
JAMA, Vol. 307, Núm. 6, pp. 573-582
-
Safety of a 2-dose regimen of a combined measles, mumps, rubella and varicella live vaccine manufactured with recombinant human albumin
Pediatric Infectious Disease Journal, Vol. 31, Núm. 11, pp. 1166-1172
2011
-
Circovirus and impact of temporary withdrawal of rotavirus vaccines in Spain
HUMAN VACCINES
-
Pharmacoeconomic assessment of implementing a universal PCV-13 vaccination programme in the Valencian public health system (Spain)
Vaccine, Vol. 29, Núm. 52, pp. 9640-9648
-
Using random networks to study the dynamics of respiratory syncytial virus (RSV) in the Spanish region of Valencia
Mathematical and Computer Modelling, Vol. 54, Núm. 7-8, pp. 1650-1654